Major shareholder announcement – BlackRock, Inc.
4 July 2024
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 271
Major shareholder announcement – BlackRock, Inc.
Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec A/S that BlackRock Investment Management (UK) Limited on 3 July 2024, increased its holding of voting rights attached to shares and voting rights in ChemoMetec A/S to above 10%, and that the holding thus exceeds the 10 per cent limit in section 38 of the Capital Markets Act.
The aggregate holding of shares and voting rights of BlackRock, Inc. in ChemoMetec A/S amounts to 14,21% of the total share capital and voting rights in ChemoMetec A/S.
For further information
CEO Martin Helbo Behrens
Phone: (+45) 4813 1020
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies.
ChemoMetec was founded in 1997 and is listed on the Nasdaq Copenhagen stock exchange. For more information, go to www.chemometec.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Steelworkers back Canada holding the line on trade, call for a stronger response to protect Canadian jobs and industry
- No. 9/2026 - CeMat A/S raises its financial guidance for 2026
- Apple TV's 'Acapulco,' Andy Garcia Lead Winners and Honorees at '41st Annual Imagen Awards' Celebrating Latino Entertainment
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share